# Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)

> **NCT04190160** · NA · COMPLETED · sponsor: **Stefano Rizza** · enrollment: 35 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DRUG:** IDegLira

## Key facts

- **NCT ID:** NCT04190160
- **Lead sponsor:** Stefano Rizza
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-19
- **Primary completion:** 2019-11-22
- **Final completion:** 2021-03-25
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2021-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04190160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04190160, "Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04190160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*